e-learning
resources
Virtual 2021
07.09.2021
Clinical features and new biomarkers of asthma, COPD and chronic cough
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough
J. Smith (Manchester (Greater Manchester), United Kingdom), D. Lamb (Biberach an der riß, Germany), R. Dockry (Manchester (Greater Manchester), United Kingdom), A. Schoenleber (Biberach an der riß, Germany), E. Benediktus (Biberach an der riß, Germany)
Source:
Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Session:
Clinical features and new biomarkers of asthma, COPD and chronic cough
Session type:
E-poster
Number:
3112
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Smith (Manchester (Greater Manchester), United Kingdom), D. Lamb (Biberach an der riß, Germany), R. Dockry (Manchester (Greater Manchester), United Kingdom), A. Schoenleber (Biberach an der riß, Germany), E. Benediktus (Biberach an der riß, Germany). Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough. 3112
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
A 41-year-old male with cough productive of yellow sputum and worsening breathlessness
Related content which might interest you:
Markers of the inflammation in patients with chronic cough
Source: Eur Respir J 2006; 28: Suppl. 50, 517s
Year: 2006
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
On relationship between local and systemic chronic inflammation and between level of hypoxia and bronchial obstruction in COPD pts
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD
Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Year: 2009
Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept